Access cutting-edge solid tumors treatment through this clinical trial at a research site in Grand Rapids. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in Grand Rapids at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
This study will be conducted to evaluate INCB177054 given as monotherapy or in combination with retifanlimab in participants with select advanced or metastatic solid Tumors.
Sponsor: Incyte Corporation
Check if you qualify for this solid tumors clinical trial in Grand Rapids, MI
If you're searching for solid tumors treatment options in Grand Rapids, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Grand Rapids research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.